Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
medicare
6
×
national
national blog main
national top stories
new york blog main
new york top stories
novartis
6
×
pfizer
6
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
drug prices
merck
president trump
amgen
biogen
bristol-myers squibb
cancer
celgene
deals
immunotherapy
What
bio
drug
roundup
patients
gene
pharmaceutical
plan
price
prices
today
acquisitions
advantages
airport
albert
alzheimer’s
annual
apocalypse
away
bar
becker
beds
biggest
billions
bourla
bringing
brings
celgene
ceo
ceos
companies
company
crispr
days
dc
different
dollars
eaton
executives
expect
fail
Language
unknown
unset
Current search:
novartis
×
pfizer
×
medicare
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More